The Converging Roles of DNA Damage Resolution and Redox Dysregulation in Plasma Cell Transformation During the Evolution of Multiple Myeloma.
- 1Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece.
- 2Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 176 76 Athens, Greece.
- 3Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
Abstract
Increasing evidence indicates that dysregulated DNA damage response (DDR) pathways and persistent oxidative stress contribute to genomic instability, increase mutational burden, and promote disease progression. This study investigated the interplay between DDR-related parameters and redox status throughout Multiple Myeloma (MM) evolution. Bone marrow plasma cells (BMPCs) from 16 patients with monoclonal gammopathy of undetermined significance (MGUS), 18 with smoldering multiple myeloma (SMM) and 15 with MM, were analyzed. Measurements included redox status, assessed by the reduced-to-oxidized glutathione (GSH-to-GSSG) ratio, abasic sites, and DDR-related parameters. Baseline DNA damage, abasic site burden, and the kinetics of UVC-induced DNA damage resolution and melphalan-induced γH2AX signal removal were progressively altered across disease stages. Moreover, disease progression was associated with a gradual decrease in chromatin condensation, apoptotic sensitivity, and the GSH-to-GSSG ratio. Multivariate statistical analyses identified distinct DDR-associated patterns that effectively discriminated among patients at different disease stages. Together, the transition from MGUS to SMM and ultimately to MM is characterized by progressive alterations in DNA damage processing, DDR-related signaling, chromatin organization, and redox status. A deeper understanding of these interconnected processes may yield valuable insights into disease progression, improve risk stratification, and guide the development of targeted therapeutic strategies for MM.
Related
- Copper homeostasis dysregulation promotes malignant transformation of renal tubular epithelial cells via the ROS/NF-κB/AID signaling axis
- Lipid Dysregulation and Impaired Resolution of Inflammation in Genetic Forms of Parkinson’s Disease: Potential Links and Knowledge Gaps
- Post-transcriptional dysregulation precedes morphological transformation in chemically induced liver cancer
- Pancreatic solid papillary neoplasm with high-grade malignant transformation and multiple hepatic metastases in an elderly male: a case report
- Endometrial evolution assessment using a high-resolution mini-hysteroscope for virtual biopsies
BibTeX
@article{malamos2026converging,
title = {{The Converging Roles of DNA Damage Resolution and Redox Dysregulation in Plasma Cell Transformation During the Evolution of Multiple Myeloma.}},
author = {Panagiotis Malamos and Konstantinos Koutoulogenis and Maria Gavriatopoulou and Evangelos Terpos and Vassilis L Souliotis},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198595},
url = {https://europepmc.org/article/MED/42883842},
note = {CC BY},
}
RIS
TY - JOUR
TI - The Converging Roles of DNA Damage Resolution and Redox Dysregulation in Plasma Cell Transformation During the Evolution of Multiple Myeloma.
AU - Panagiotis Malamos
AU - Konstantinos Koutoulogenis
AU - Maria Gavriatopoulou
AU - Evangelos Terpos
AU - Vassilis L Souliotis
PY - 2026
DA - 2026/09/25
JO - International journal of molecular sciences
DO - 10.3390/ijms27198595
UR - https://europepmc.org/article/MED/42883842
AB - Increasing evidence indicates that dysregulated DNA damage response (DDR) pathways and persistent oxidative stress contribute to genomic instability, increase mutational burden, and promote disease progression. This study investigated the interplay between DDR-related parameters and redox status throughout Multiple Myeloma (MM) evolution. Bone marrow plasma cells (BMPCs) from 16 patients with monoclonal gammopathy of undetermined significance (MGUS), 18 with smoldering multiple myeloma (SMM) and 15 with MM, were analyzed. Measurements included redox status, assessed by the reduced-to-oxidized glutathione (GSH-to-GSSG) ratio, abasic sites, and DDR-related parameters. Baseline DNA damage, abasic site burden, and the kinetics of UVC-induced DNA damage resolution and melphalan-induced γH2AX signal removal were progressively altered across disease stages. Moreover, disease progression was associated with a gradual decrease in chromatin condensation, apoptotic sensitivity, and the GSH-to-GSSG ratio. Multivariate statistical analyses identified distinct DDR-associated patterns that effectively discriminated among patients at different disease stages. Together, the transition from MGUS to SMM and ultimately to MM is characterized by progressive alterations in DNA damage processing, DDR-related signaling, chromatin organization, and redox status. A deeper understanding of these interconnected processes may yield valuable insights into disease progression, improve risk stratification, and guide the development of targeted therapeutic strategies for MM.
SN - 1422-0067
ER -